| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Director | Common Stock | 30K | $397K | $13.24 | Sep 12, 2024 | Direct |
| Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.7K | Jun 9, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Jun 9, 2025 | 1 | $0 | 4 | Jun 10, 2025 | Director |
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 1 | $0 | 4 | Sep 16, 2024 | Director |
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | Director |